Literature DB >> 32586449

Generation of multi-cellular human liver organoids from pluripotent stem cells.

Wendy L Thompson1, Takanori Takebe2.   

Abstract

A growing number of in vitro hepatic models exist to study human genetics, liver biology, disease modeling and drug development and range from 2D hepatocytes to 3D multi-cellular tissues that are derived from human stem cells. However, stem cell-based models generally suffer from batch-, clone- and donor-dependent variability, hindering broader usage in diverse biomedical applications. To circumvent this challenge, we herein describe a reproducible protocol to generate human liver organoids in 20-25 days derived from pluripotent stem cells (PSCs). These organoids are intra-luminally polarized to form canalicular structures and are comprised of mainly hepatic epithelial cells, co-differentiated with stellate-like and hepatic macrophage-like cells that enables hepatic inflammatory disease modeling in vitro. These multi-lineage liver organoids express hepatocyte genes, secrete albumin and have vital metabolic functions. This protocol utilizes PSC derived 3D human liver organoids as a renewable, reproducible and personalized cell source, thus facilitating disease modeling and mechanistic studies with a future goal of developing novel therapeutics against currently intractable diseases.
© 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Human liver organoids; Pluripotent stem cells; Self-organization; Steatohepatitis

Year:  2020        PMID: 32586449      PMCID: PMC8011941          DOI: 10.1016/bs.mcb.2020.03.009

Source DB:  PubMed          Journal:  Methods Cell Biol        ISSN: 0091-679X            Impact factor:   1.441


  28 in total

1.  Measurement of Blood Coagulation Factor Synthesis in Cultures of Human Hepatocytes.

Authors:  Stefan Heinz; Joris Braspenning
Journal:  Methods Mol Biol       Date:  2015

Review 2.  Cellular homeostasis and repair in the mammalian liver.

Authors:  Ben Z Stanger
Journal:  Annu Rev Physiol       Date:  2015       Impact factor: 19.318

Review 3.  In vitro platforms for evaluating liver toxicity.

Authors:  Shyam Sundhar Bale; Lawrence Vernetti; Nina Senutovitch; Rohit Jindal; Manjunath Hegde; Albert Gough; William J McCarty; Ahmet Bakan; Abhinav Bhushan; Tong Ying Shun; Inna Golberg; Richard DeBiasio; Berk Osman Usta; D Lansing Taylor; Martin L Yarmush
Journal:  Exp Biol Med (Maywood)       Date:  2014-04-24

Review 4.  Mechanisms of Drug-Induced Hepatotoxicity.

Authors:  Amina Ibrahim Shehu; Xiaochao Ma; Raman Venkataramanan
Journal:  Clin Liver Dis       Date:  2017-02       Impact factor: 6.126

5.  Generation of human antral and fundic gastric organoids from pluripotent stem cells.

Authors:  Taylor R Broda; Kyle W McCracken; James M Wells
Journal:  Nat Protoc       Date:  2019-01       Impact factor: 13.491

6.  Generation of hepatobiliary organoids from human induced pluripotent stem cells.

Authors:  Fenfang Wu; Di Wu; Yong Ren; Yuhua Huang; Bo Feng; Nan Zhao; Taotao Zhang; Xiaoni Chen; Shangwu Chen; Anlong Xu
Journal:  J Hepatol       Date:  2019-01-07       Impact factor: 25.083

Review 7.  Drug-induced liver injury: Advances in mechanistic understanding that will inform risk management.

Authors:  M Mosedale; P B Watkins
Journal:  Clin Pharmacol Ther       Date:  2017-01-11       Impact factor: 6.875

8.  Human primary liver cancer-derived organoid cultures for disease modeling and drug screening.

Authors:  Laura Broutier; Gianmarco Mastrogiovanni; Monique Ma Verstegen; Hayley E Francies; Lena Morrill Gavarró; Charles R Bradshaw; George E Allen; Robert Arnes-Benito; Olga Sidorova; Marcia P Gaspersz; Nikitas Georgakopoulos; Bon-Kyoung Koo; Sabine Dietmann; Susan E Davies; Raaj K Praseedom; Ruby Lieshout; Jan N M IJzermans; Stephen J Wigmore; Kourosh Saeb-Parsy; Mathew J Garnett; Luc Jw van der Laan; Meritxell Huch
Journal:  Nat Med       Date:  2017-11-13       Impact factor: 53.440

9.  Robust, Long-Term Culture of Endoderm-Derived Hepatic Organoids for Disease Modeling.

Authors:  Soheil Akbari; Gülben Gürhan Sevinç; Nevin Ersoy; Onur Basak; Kubra Kaplan; Kenan Sevinç; Erkin Ozel; Berke Sengun; Eray Enustun; Burcu Ozcimen; Alper Bagriyanik; Nur Arslan; Tamer Tevfik Önder; Esra Erdal
Journal:  Stem Cell Reports       Date:  2019-09-12       Impact factor: 7.765

10.  Mechanistic evaluation of primary human hepatocyte culture using global proteomic analysis reveals a selective dedifferentiation profile.

Authors:  James A Heslop; Cliff Rowe; Joanne Walsh; Rowena Sison-Young; Roz Jenkins; Laleh Kamalian; Richard Kia; David Hay; Robert P Jones; Hassan Z Malik; Stephen Fenwick; Amy E Chadwick; John Mills; Neil R Kitteringham; Chris E P Goldring; B Kevin Park
Journal:  Arch Toxicol       Date:  2016-04-02       Impact factor: 5.153

View more
  6 in total

1.  Comparison of Microglial Morphology and Function in Primary Cerebellar Cell Cultures on Collagen and Collagen-Mimetic Hydrogels.

Authors:  Zbigniev Balion; Nataša Svirskienė; Gytis Svirskis; Hermanas Inokaitis; Vytautas Cėpla; Artūras Ulčinas; Tadas Jelinskas; Romuald Eimont; Neringa Paužienė; Ramūnas Valiokas; Aistė Jekabsone
Journal:  Biomedicines       Date:  2022-04-29

Review 2.  Liver organoids in domestic animals: an expected promise for metabolic studies.

Authors:  Camille Baquerre; Guillaume Montillet; Bertrand Pain
Journal:  Vet Res       Date:  2021-03-18       Impact factor: 3.683

Review 3.  Applied Hepatic Bioengineering: Modeling the Human Liver Using Organoid and Liver-on-a-Chip Technologies.

Authors:  Kayque Alves Telles-Silva; Lara Pacheco; Sabrina Komatsu; Fernanda Chianca; Luiz Carlos Caires-Júnior; Bruno Henrique Silva Araujo; Ernesto Goulart; Mayana Zatz
Journal:  Front Bioeng Biotechnol       Date:  2022-02-14

4.  Induced Endothelial Cell-Integrated Liver Assembloids Promote Hepatic Maturation and Therapeutic Effect on Cholestatic Liver Fibrosis.

Authors:  Donggyu Nam; Myung Rae Park; Hyunah Lee; Sung Chul Bae; Daniela Gerovska; Marcos J Araúzo-Bravo; Holm Zaehres; Hans R Schöler; Jeong Beom Kim
Journal:  Cells       Date:  2022-07-19       Impact factor: 7.666

5.  High-throughput bioengineering of homogenous and functional human-induced pluripotent stem cells-derived liver organoids via micropatterning technique.

Authors:  Xiaodong Xu; Shanqing Jiang; Longjun Gu; Bin Li; Fang Xu; Changyong Li; Pu Chen
Journal:  Front Bioeng Biotechnol       Date:  2022-08-10

6.  HiPSC-Derived Hepatocyte-like Cells Can Be Used as a Model for Transcriptomics-Based Study of Chemical Toxicity.

Authors:  Sreya Ghosh; Jonathan De Smedt; Tine Tricot; Susana Proença; Manoj Kumar; Fatemeharefeh Nami; Thomas Vanwelden; Niels Vidal; Paul Jennings; Nynke I Kramer; Catherine M Verfaillie
Journal:  Toxics       Date:  2021-12-21
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.